Roel Bulthuis
Managing Partner at Syncona Limited
Amsterdam, North Holland
Overview
Work Experience
Managing Partner
2023 - Current
Enjoying the sun
2023 - 2023
Managing Director
2019 - 2023
Senior Vice President & Managing Director
2015 - 2018
We drive innovation and back entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of Merck’s current and future businesses. We are the strategic, corporate venture capital arm of Merck. Our mandate is to invest in innovative technologies and products with the potential to significantly impact Merck’s core business areas. From our headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. We take an active role in our portfolio companies and team up with entrepreneurs and co-investors to translate innovation towards commercial success. We have a significant focus on early stage investing and company creation including the creation of spin-offs to leverage Merck’s science and technology base.
Senior Vice President & Managing Director
2009 - 2018
Senior Director, Head of Merck Serono Ventures
2009 - 2015
Director, Head of Venture Capital Scouting
2007 - 2009
Associate Director, Corporate M&A
2006 - 2007
EMD Serono, Inc. discovers and develops biopharmaceutical products. The company focuses on specialized areas, such as neurodegenerative
Director-Biotechnology Investment Banking
2000 - 2005
Business Development
2000 - 2000